Controlling new psychoactive substances in New Zealand
Open Access
- 10 May 2022
- journal article
- research article
- Published by Taylor & Francis Ltd in Australian Journal of Forensic Sciences
- Vol. 55 (5), 670-688
- https://doi.org/10.1080/00450618.2022.2067230
Abstract
The emergence of new psychoactive substances into the global drug market has presented challenges for effective drug legislation and enforcement. One approach to prohibition uses controlled drug analogue legislation, which involves assessing the structural similarity of new substances compared to listed controlled drugs, as opposed to the new substance being specifically listed in legislation itself. An issue arises of there being no clear definition for what constitutes similarity between two substances, and as such, there is level of subjectivity in any decision made. This paper outlines the global and local drug scene in New Zealand, including the emergence of new psychoactive substances, and the legislation that is available for the control of illicit substances in a New Zealand context and the current method for considering new psychoactive substances as potential controlled drug analogues. The authors go on to propose an alternative method to this assessment process, which involves an objective and reproducible similarity scoring mechanism.Keywords
This publication has 25 references indexed in Scilit:
- Toxicities Associated With NBOMe Ingestion—A Novel Class of Potent Hallucinogens: A Review of the LiteraturePsychosomatics, 2014
- New psychoactive substances: issues about the new approach from New Zealand governmentAddiction, 2014
- 2C-I-NBOMe, an “N-bomb” that kills with “Smiles”. Toxicological and legislative aspectsDrug and Chemical Toxicology, 2014
- The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sampleJournal of Psychopharmacology, 2014
- The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislationJournal of Cheminformatics, 2014
- 25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic DrugBioMed Research International, 2014
- New “party pill” components in New Zealand: The synthesis and analysis of some β-ketone analogues of 3,4-methylenedioxymethamphetamine (MDMA) including βk-DMBDB (β-ketone-N,N-dimethyl-1-(1,3-benzodioxol-5-yl)-2-butanamine)Forensic Science International, 2011
- Benzylpiperazine in New Zealand: brief history and current implicationsJournal of the Royal Society of New Zealand, 2011
- Extended-Connectivity FingerprintsJournal of Chemical Information and Modeling, 2010
- The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service.Journal of Chemical Documentation, 1965